whats REDEFINE testing exactly
i keep the two on separate days so if something goes wrong i have a chance of knowing which
#cagrilintide 2025-12-11
Thursday28 messages6 participantstimes are UTC
Highlights from this day
- split_shipment — whats REDEFINE testing exactly i keep the two on separate days so if something goes wrong i have a chance of knowing which 17:16
- turnaround_tam — the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair, not advice obviously 18:15
- rotate_the_site — added it to an existing retatrutide dose rather than starting both, which made attribution possible, ymmv 19:15
- turnaround_tam — its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake, thats just me 19:22
- chlorhex — the fullness thing is the part people describe differently, food stops being interesting rather than repellent, ask me again in a month CagriSema is cagrilintide with… 21:10
update on the earlier thing 40 in 2ml gives 4mg/ml which is what i use, purely because the units come out round
follow up back after 26 months, is monotherapy still a minority thing here
*Medutest not the other one
right so you cannot tell which of the two is doing what in a combination and i stopped pretending i could
is anyone running this on its own or is it all CagriSema in here
for the archive combination GI was worse than either alone for me, which is not what i had read anywhere
the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair, not advice obviously
amylin analogue, so its not a GLP-1 at all right
anyone stopped the GLP-1 and kept only this
lost 34lb over 8 months on the combination and i genuinely cannot apportion it
cant separate them
does the fullness effect fade the way appetite suppression does
has REDEFINE reported or are people quoting earlier work
is the combination just the two dosed together or a single formulation
[edited]REDEFINE is the trial
🤝4💀8🧊3
added it to an existing retatrutide dose rather than starting both, which made attribution possible, ymmv
👀2😂1
amylin not glp-1
the nausea felt different rather than less, more fullness and less of the queasy wave
its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake, thats just me
how slow are people titrating this compared to tirzepatide
did anyone add this to an existing semaglutide dose rather than starting both
is 2.4 the number for this too or am i confusing compounds
turnaround_tamright so you cannot tell which of the two is doing what in a combination and i stopped…
held at 2 for 5 months on monotherapy before i touched it again
fullness rather than nausea
*Janoshik not the other one
the fullness thing is the part people describe differently, food stops being interesting rather than repellent, ask me again in a month
CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it
cagrisema thats it